Status and phase
Conditions
Treatments
About
Evaluate changes in tear film osmolarity and other DED signs/symptoms following treatment with IPL.
Full description
Prospective study design among subjects with MGD and qualifying for IPL therapy.
Study testing done at baseline visit when subjects are scheduled for IPL therapy. Measurements will be made on day 15 (prior to second IPL sitting), Day 45 (prior to third IPL setting), Day 75 (fourth IPL setting) and Day 105 as needed (30 days after IPL setting 4).
Subjects willing to come for follow up visits as scheduled and may not have instilled any artificial tears 2 hours prior to study measurements.
No history of ocular infection or corneal degeneration/dystrophy No history of corneal refractive surgery and/or change in ocular medications in the last 2 months
Enrollment
Sex
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
60 participants in 1 patient group
Loading...
Central trial contact
Francesco Carones, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal